Dopamine agonist therapy induces significant recovery of HPA axis function in prolactinomas independent of tumor size: a large single center experience

Research output: Contribution to journalArticle

Abstract

Our objective was to compare prevalence and rates of recovery of hypothalamic–pituitary–adrenal axis dysfunction in prolactinoma patients before and after dopamine agonist therapy with nonfunctioning pituitary adenoma patients pre-transsphenoidal and post-transsphenoidal surgery. We retrospectively compared hypothalamic–pituitary–adrenal axis function in patients with prolactinomas naïve to dopamine agonist therapy with a cohort of nonfunctioning pituitary adenoma patients matched for gender and tumor size by classification (n = 57; 30 male/27 female; 27 microadenoma/30 macroadenoma). Patients with

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalEndocrine
DOIs
StateAccepted/In press - Jul 26 2016

Keywords

  • Adrenal insufficiency
  • Hypopituitarism
  • Nonfunctioning pituitary adenomas
  • Prolactinomas
  • Recovery of adrenal function

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Dopamine agonist therapy induces significant recovery of HPA axis function in prolactinomas independent of tumor size: a large single center experience'. Together they form a unique fingerprint.

  • Cite this